Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Agricultural Development Bank of China
International Relation

World Insights: China's vaccine cooperation gains momentum worldwide

January 20, 2021


Abstract : With Chinese-made vaccine shots reaching people in more countries, booming vaccine cooperation with China worldwide is injecting confidence into the global fight against the ravaging COVID-19 pandemic.

A staff member checks the packaging quality of COVID-19 inactivated vaccine products at a packaging plant of the Beijing Biological Products Institute Co., Ltd. in Beijing, capital of China, Dec. 25, 2020. (Xinhua/Zhang Yuwei)

- "As an ordinary person and the president of Serbia, I am convinced of the quality of the Chinese vaccine, which will be decided by our competent agency," Serbian President Aleksandar Vucic said.

- Specialists decided that "the best vaccine for Azerbaijan is the vaccine of the Sinovac company," as it has passed clinical tests in many countries, said Azerbaijani Health Minister Ogtay Shiraliyev.

BEIJING, Jan. 19 (Xinhua) -- With Chinese-made vaccine shots reaching people in more countries, booming vaccine cooperation with China worldwide is injecting confidence into the global fight against the ravaging COVID-19 pandemic.

VACCINATION DRIVE

Serbian health authorities approved the use of Sinopharm's COVID-19 vaccines on Monday evening, two days after a million doses were imported from China, enabling the country to start mass immunization of its population.

One million doses of Sinopharm's vaccine arrived in Serbia on Saturday and were welcomed at the Belgrade Airport by President Aleksandar Vucic, who confirmed that he will receive the vaccine himself.

Serbian President Aleksandar Vucic (C) and China's ambassador to Serbia Chen Bo (L) welcome the shipment of China's Sinopharm inactivated coronavirus vaccines at the Belgrade Airport, Serbia, Jan. 16, 2021.  (Photo by Predrag Milosavljevic/Xinhua)

Meanwhile, the Drug Regulatory Authority of Pakistan (DRAP) has approved the Sinopharm vaccine for emergency use amid rising cases of COVID-19 in the country.

A handout by DRAP on its official website late Monday read that Sinopharm, one of the two vaccines approved by the authority, has been given emergency use authorization after evaluating its safety and quality.

Also on Monday, Brazil launched its mass vaccination campaign against the virus simultaneously in each state, after Brazil's health regulatory agency on Sunday authorized the emergency use of two vaccines, one by the Chinese company Sinovac as well as the other by AstraZeneca and Oxford University.

Dulcinea da Silva Lopes (R), a 59-year-old mediacal worker, receives a dose of China's COVID-19 vaccine in Rio de Janeiro, Brazil, Jan. 18, 2021. (Brazilian National News Agency/Handout via Xinhua)

In Azerbaijan, senior health officials on Monday took their first inoculation of the Sinovac vaccine, marking the beginning of mass immunization against COVID-19 in the country, according to state-run news agency AZERTAC.

POSITIVE FEEDBACK

The Agency for Medicines and Medical Devices of Serbia and its employees "assessed the necessary documentation and scientific evidence in a highly professional and thorough manner according to all European Union and World Health Organization (WHO) standards, which confirmed the quality, efficiency, and above all the safety of the Chinese vaccine," Pavle Zelic, an official with the agency, told local media.

"As an ordinary person and the president of Serbia, I am convinced of the quality of the Chinese vaccine, which will be decided by our competent agency," Vucic said when welcoming the arrival of the Chinese vaccine on Saturday.

Turkish President Recep Tayyip Erdogan said Friday he did not see any side effects of the COVID-19 vaccine that he received the previous day.

On Thursday, Turkey started its mass vaccination program with the COVID-19 vaccines developed by Sinovac.

A medical worker receives a dose of China's Sinovac COVID-19 vaccine at the Sabiha Uzun Maternal Child Health Center in Ankara, Turkey on Jan. 15, 2021. (Photo by Mustafa Kaya/Xinhua)

Specialists decided that "the best vaccine for Azerbaijan is the vaccine of the Sinovac company," as it has passed clinical tests in many countries, said Azerbaijani Health Minister Ogtay Shiraliyev, when addressing local media after being inoculated on Monday.

Similarly, "Azerbaijan got the most safe and effective vaccine," said Shahmar Movsumov, assistant to the president of Azerbaijan, as he praised the Chinese-made jab two days earlier.

CHALLENGES AHEAD

As an increasing number of countries started mass vaccination, the world finally sees the light at the end of the tunnel. Yet, even in some developed countries, the public is not satisfied with the vaccination campaigns.

In the United States, health experts and officials have blamed states for slow vaccine rollout. The country planned to immunize 20 million Americans by the end of 2020. However, only about 12.28 million total doses have been administered as of Jan. 15, according to the U.S. Centers for Disease Control and Prevention.

Residents receive COVID-19 vaccines in Pasadena, Los Angeles County, California, the United States, Jan. 15, 2021. (Xinhua)

Also, the slowdown in vaccine arrivals has sparked complaints in Europe.

More worryingly, WHO chief Tedros Adhanom Ghebreyesus on Monday warned of the moral consequences of the lack of COVID-19 vaccines for poorer countries, saying that the higher-income countries are privileged compared to the developing countries.

"More than 39 million doses of vaccine have now been administered in at least 49 higher-income countries. Just 25 doses have been given in one lowest-income country. Not 25 million, not 25 thousand, just 25," he said.

Meanwhile, UN Secretary-General Antonio Guterres on Monday called for solidarity with developing countries in the context of COVID-19 and pre-exisiting inequalities and injustices.

Vaccines must be a global public good, available to everyone, everywhere, he said.

The good news is that China has, on various occasions, pledged continuous efforts in global COVID-19 response.

Chinese State Councilor and Foreign Minister Wang Yi has recently said that China will continue to advance global cooperation on epidemic response, strengthen joint prevention and control, and assist countries and regions in need.

"We were the first to pledge to make vaccines a global public good, bearing in mind the greater good of humanity," he said.

James Nyirenda, a biochemist in Zambia, said China is providing support to Africa at a critical time to help fight the COVID-19 pandemic.

"China has really helped. We are yet to see test kits or even vaccines from the West and other big countries," said Nyirenda.

Scan the QR code and push it to your mobile phone

Keyword: vaccine cooperation

Reading:

Philippine President Duterte praises safety of Chinese COVID-19 vaccine

Turkish doctors hail Chinese vaccine drive as hope against COVID-19

Xinhua Commentary: China's historic economic comeback, beacon of hope for world

China, Cambodia to enhance cooperation, boost ties

Pakistan approves China's Sinopharm COVID-19 vaccine for emergency use

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial